Abstract
Class III antiarrhythmic agents may prolong refractoriness via modulation of ion channels, which may be sensitive to Ca2+ regulatory proteins or enzymes. Accordingly, the purpose of this study was to quantitate the effects of several structurally diverse class III antiarrhythmic agents on calmodulin-regulated enzymes and protein kinase C activity, and to evaluate the ability of these agents and known calmodulin antagonists to prolong cardiac refractoriness in vivo. The rank order of potency (IC50;microM) of selected class III antiarrhythmic agents and reference calmodulin antagonists as inhibitors of calmodulin-regulated phosphodiesterase activity were: calmidazolium (0.12 microM) greater than amiodarone (0.62 microM) greater than desethylamiodarone (1.5 microM) greater than trifluoperazine (4.3 microM), bepridil (5 microM) greater than W-7 (7.5 microM), clofilium (13 microM). Similar concentration-related inhibition was evident in a second calmodulin-regulated system, inhibition of myosin light-chain phosphorylation and superprecipitation of arterial actomyosin. Sotalol and tetraethylammonium were inactive at 100 microM. Protein kinase C activity was also inhibited by some of these agents; desethylamiodarone (IC50 = 11 microM)...Continue Reading
References
Apr 1, 1979·The Journal of Physiology·D DiFrancesco, P A McNaughton
May 7, 1976·Analytical Biochemistry·M M Bradford
Jan 1, 1985·The Journal of Membrane Biology·I B Levitan
May 20, 1988·European Journal of Pharmacology·P J SilverD B Evans
Nov 1, 1985·Biochemical Pharmacology·J M LamersP D Verdouw
Mar 1, 1986·Biochemical Pharmacology·R E WeishaarD B Evans
Nov 1, 1986·British Journal of Pharmacology·E BarronE Winslow
Jan 1, 1974·Methods in Enzymology·J D Corbin, E M Reimann
Oct 12, 1981·FEBS Letters·I Lackington, F Orrego
Apr 1, 1984·Journal of Clinical Pharmacology·E M Vaughan Williams
Oct 1, 1984·European Journal of Pharmacology·G BkailyM Eldefrawi
Jul 16, 1984·European Journal of Biochemistry·M Zimmer, F Hofmann
Jan 1, 1984·Biochemical Pharmacology·G J MazzeiJ F Kuo
Oct 1, 1983·American Heart Journal·D W HoltG C Storey
Apr 1, 1984·Biophysical Journal·R S Kass
Citations
Aug 21, 1992·Pharmaceutisch Weekblad. Scientific Edition·R Mannhold, H Timmerman
Sep 25, 2009·Naunyn-Schmiedeberg's Archives of Pharmacology·Jakob GiertenDierk Thomas
Feb 5, 2000·Cancer Letters·B Y ChoiG Kong
Jul 1, 1993·British Journal of Pharmacology·H SakutaY Watanabe
Jan 8, 2005·Pharmacology·Aizhen YangShan Ping Yu
Dec 21, 2002·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Toru Maruyama, Hiroyuki Ito
Nov 26, 1993·The American Journal of Cardiology·L Ceremuzyński
Oct 25, 2016·Molecular Neurobiology·Rifang LiaoWenhua Zheng
Jan 1, 1991·Hypertension·R A BuchholzP J Silver
May 1, 1999·Circulation Research·Y WuM E Anderson
Feb 23, 2018·Neuro-ophthalmology·Katrin FaslerKlara Landau
Jan 1, 1997·Life Sciences·J D RabinowitzH M McConnell